Skip to main navigation Skip to search Skip to main content

Optimizing risk factors to guide COST-effective use of palivizumab in KOREAN infants

  • Ji Man Kang
  • , Xavier Carbonell-Estrany
  • , Bosco Paes
  • , Barry Rodgers-Gray
  • , John Fullarton
  • , Jean Eric Tarride
  • , Hyeon Jong Yang
  • , Yun Sil Chang
  • , Ian Keary
  • Yonsei University
  • Hospital Clinic Barcelona
  • McMaster University
  • Violicom Medical Limited
  • Soonchunhyang University

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Optimizing risk factors to guide COST-effective use of palivizumab in KOREAN infants'. Together they form a unique fingerprint.
Sort by

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences

Immunology and Microbiology